AIxBio RegistryAI molecules in the clinic

When, what for, and what the AI did

Computed in your browser from the registry's data each time the page loads. The strict cohort is shown by default. Including the borderline entries gives a count closer to published lists of “AI-enabled” assets. How far each molecule has got, phase by phase, is compared with industry rates on The question.

First dosed in people, by year

The chart needs the registry data to load. The CSV download has the same figures.

Show as a table

What the AI did, by year first dosed

The step the developer's own claim credits to AI

    Show as a table

    Therapeutic area

    Molecules by the area of their lead indication

    Coded from each entry's lead indication by an AI agent and not yet reviewed by the maintainer (Methodology § 3); corrections are welcome.

    Show as a table

    Modality

    Molecules by kind of medicine

    One class per entry. Antibodies include antibody-drug conjugates and bispecifics; peptides are 40 amino acids or fewer; “Other” holds oligonucleotides, mRNA medicines that are not vaccines and phages (Methodology § 3).

    Show as a table